This suggests that the CD204 high-expression group exhibited greater immunosuppressive activity within ccRCC tissues, creating an immunosuppressive microenvironment that could potentially facilitate tumor progression. This evidence concerns the gene MSR1 and nonpapillary renal cell carcinoma.